Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
The American Journal of Pathology|November 10, 2011
Tumor cell cross talk with tumor-associated leukocytes leads to induction of tumor exosomal fibronectin and promotes tumor progressionZhongBin Deng, Ziqiang Cheng, Xiaoyu Xiang, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 20, 2014
The protective effect of p16(INK4a) in oral cavity carcinomas: p16(Ink4A) dampens tumor invasion-integrated analysis of expression and kinomics pathwaysTatyana Isayeva, Jie Xu, Camille Ragin, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2013
Exosome-like nanoparticles from intestinal mucosal cells carry prostaglandin E2 and suppress activation of liver NKT cellsZhong-Bin Deng, Xiaoying Zhuang, Songwen Ju, et al.Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|November 26, 2005
Implementation of accurate and fast DNA cytometry by confocal microscopy in 3DLennert S Ploeger, André Huisman, Jurryt van der Gugten, et al.Plos One|July 7, 2012
A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung diseasePeter A Sloane, Suresh Shastry, Andrew Wilhelm, et al.Biopreservation and Biobanking|May 20, 2016
A Biospecimen Proficiency Testing Program for Biobank Accreditation: Four Years of ExperienceAmélie Gaignaux, Garry Ashton, Domenico Coppola, et al.World Journal of Translational Medicine|December 20, 2014
Epithelial ovarian cancer: An overviewArpita Desai, Jingyao Xu, Kartik Aysola, et al.Oncotarget|October 21, 2017
Phosphodiesterase 10A is overexpressed in lung tumor cells and inhibitors selectively suppress growth by blocking β-catenin and MAPK signalingBing Zhu, Ashley Lindsey, Nan Li, et al.Cancers|May 16, 2023
Immune Profile of Exosomes in African American Breast Cancer Patients Is Mediated by Kaiso/THBS1/CD47 SignalingMd Shakir Uddin Ahmed, Brittany D Lord, Benjamin Adu Addai, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2015
TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast CancerAndres Forero-Torres, Katherine E Varley, Vandana G Abramson, et al.Pageof 5